Violenza666
Bluelighter
Pain Patch Technology Moves Forward
July 2010
Phosphagenics Ltd continues to move ahead with the development of its “pain patch”, a new way of delivering the commonly used painkiller oxycodone. Oxycodone, an opioid, is one of the world’s leading pain management drugs with worldwide sales exceeding US$3 billion annually.
In a previously conducted pharmacokinetic study involving the daily administration of a patch to healthy volunteers, Phosphagenics demonstrated that its TPM/oxycodone patch delivered therapeutic levels of oxycodone to healthy volunteers over a number of days.
The company is announcing the commencement of the next phase of clinical development for its proprietary system which uses TPM™ technology to deliver pain relief transdermally, that is, through the skin.
Chief Executive Officer, Dr Esra Ogru, said recruitment has begun for the next stage clinical trial which is designed to identify the dosing parameters best suited for use in the upcoming Phase II/III clinical trial.
Full Story here: http://www.ddw-online.com/industrynews/528117/pain_patch_technology_moves_forward.html
July 2010
Phosphagenics Ltd continues to move ahead with the development of its “pain patch”, a new way of delivering the commonly used painkiller oxycodone. Oxycodone, an opioid, is one of the world’s leading pain management drugs with worldwide sales exceeding US$3 billion annually.
In a previously conducted pharmacokinetic study involving the daily administration of a patch to healthy volunteers, Phosphagenics demonstrated that its TPM/oxycodone patch delivered therapeutic levels of oxycodone to healthy volunteers over a number of days.
The company is announcing the commencement of the next phase of clinical development for its proprietary system which uses TPM™ technology to deliver pain relief transdermally, that is, through the skin.
Chief Executive Officer, Dr Esra Ogru, said recruitment has begun for the next stage clinical trial which is designed to identify the dosing parameters best suited for use in the upcoming Phase II/III clinical trial.
Full Story here: http://www.ddw-online.com/industrynews/528117/pain_patch_technology_moves_forward.html
